Guest Speaker Series
Thursday, August 25, 2022
Keith Humphreys, PhD
Keith Humphreys is the Esther Ting Memorial Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He is also a Senior Research Career Scientist at the VA Health Services Research Center in Palo Alto. His research addresses the prevention and treatment of addictive disorders and interplay of science with public policy.
Dr. Humphreys has been extensively involved in the formation of public policy, having testified to Congress on multiple occasions, and having served as a member of the White House Commission on Drug Free Communities, the VA National Mental Health Task Force, and the National Advisory Council of the U.S. Substance Abuse and Mental Health Services Administration. During the Obama Administration, he spent a sabbatical year as Senior Policy Advisor at the White House Office of National Drug Control Policy. He has also testified on numerous occasions in the U.K. Parliament and advises multiple government agencies in the U.K. He created and co-directs the Stanford Network on Addiction Policy, which brings scientists and policy makers together to improve public policies regarding addictive substances. He is also leading the Stanford-Lancet Commission on the North American Opioid Crisis.
VIRTUAL LECTURE | August 25, 2022
The Stanford-Lancet Commission on the North American Opioid Crisis
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Medical Association (AMA)
Stanford Medicine designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Council of Pharmacy Education (ACPE)
Stanford Medicine designates this knowledge-based activity for a maximum of 1 hour. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number List: JA0000751-0000-22-012-L08-P
American Nurses Credentialing Center (ANCC)
Stanford Medicine designates this live activity for a maximum of 1.0 ANCC contact hour.
ASWB Approved Continuing Education Credit (ACE)
As a Jointly Accredited Organization, Stanford Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Stanford Medicine maintains responsibility for this course. Social workers completing this activity receive 1.0 live continuing education credits.
American Psychological Association (APA)
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.
American Academy of PAs (AAPA)
Stanford Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This live activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Stanford Health Care Department of Rehabilitation is an approved provider for physical therapy and occupational therapy for courses that meet the requirements set forth by the respective California Boards. This course is approved for 1.0 hour CEU for PT and OT.
Friday, September 9, 2022
Howard Fields, MD, PhD
Howard Fields received his MD and PhD in Neuroscience at Stanford in 1965-66. Following clinical training in neurology at Harvard Medical School in 1972, he joined the faculty of the University of California San Francisco, where he is currently Professor of Neurology and Physiology Emeritus. He was a founder of the UCSF pain management center and made major contributions to understanding and treating post-herpetic neuralgia, including demonstrating the effectiveness of opioids and topical lidocaine. In laboratory studies with Allan Basbaum, he discovered and elucidated a pain modulating neural circuit that engages endogenous opioids and is activated by opioid analgesics. Furthermore, with Jon Levine he discovered that placebo analgesia can be blocked by an opioid antagonist. He received numerous awards including the National Migraine Foundation Award, the Bristol-Myers Award for Pain Research, a Merit Award from NIH, the Kerr Award of the American Pain Society, the Cotzias Award of the American Academy of Neurology. He also gave the Beecher Lecture and later the Adams Lecture at Harvard Medical School. In 1997, he was elected to membership in the Institute of Medicine and in 2010 to the American Academy of Arts and Sciences. In 2018-19 he served as a member of the Congressionally mandated pain management task force to develop guidelines for the treatment of chronic pain.
VIRTUAL LECTURE | September 9, 2022
Self-Fulfilling Prophesies: How Predictions and Expectations Modulate Pain